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Over the last decades, substantial developments in 
retinal imaging offered a paradigmatic change in the 
understanding of the pathophysiology of wet age-related 
macular degeneration (AMD). We have reached a point of 
sophistication that seemed unattainable a few years ago. A 
myriad of imaging devices is now available at our discretion, 
representing a unique opportunity to offer our patients 
better clinical care. In order to reduce the risk of progressive 
and enduring visual loss associated with wet AMD, 
early identification and prompt initiation of treatment is 
warranted. Since its introduction in 1961 by Novotny and 
Alvis (1), fluorescein angiography (FA) became the gold 
standard for the diagnosis and classification of choroidal 
neovascularization (CNV). However, a major limitation 
of traditional angiography resides in its inability to image 
the entire retinal capillary system or to directly visualize 
new vessels, resorting on indirect clues such as fluid 
accumulation or leakage to recognize neovascularization (2). 
Wide-field image acquisition, confocal scanning laser 
ophthalmoscopy, adaptive optics and indocyanine 
green angiography (ICGA) have broadened the use of 
classic angiography. With complementary ICGA, better 
visualization of the deep vessels can be obtained due to peak 
excitation (805 nm) and emission (835 nm) in the near-
infrared region. Nevertheless, ICGA is neither available nor 
routinely performed in many institutions throughout the 
world. Also, despite the ability to detect dynamic patterns 
of dye transit and leakage, angiography systems (FA and 
ICGA) remain expensive, time-consuming and invasive 
procedures. Although generally safe, side effects like nausea; 
vomiting or even severe allergic reactions may develop in a 
minority of patients, thus limiting its repeated use (3).
The advent of optical coherence tomography (OCT) 
revolutionized retinal imaging by providing a fast, simple, 
and noninvasive method to assess retinal structure at a 
microscopic level. Since its debut more than two decades 
ago, profound improvements in the scanning speed, 
resolution and image depth led to an explosive growth of 
OCT in clinical practice, with a significant effect in clinical 
decision making (4). Even though technical sophistication 
improved the OCT diagnostic yield for wet AMD, there 
are no agreed-on standards for diagnosing CNV based 
strictly on cross-sectional OCT (5). Structural OCT cannot 
detect blood flow, nor can it reliably distinguish vasculature 
from fibrous and other surrounding tissue (6). Therefore, 
structural OCT must ultimately be used in combination 
with angiography systems to diagnose CNV accurately.
By conveying noninvasive, three-dimensional scans of 
both the superficial and deep retinal capillary plexuses and 
the choriocapillaris, OCT angiography (OCTA) brought a 
new insight into the vascular abnormalities that accompany 
neovascularization. OCTA detects endoluminal flow by 
mapping erythrocyte movement over time and comparing 
sequential OCT B-scans at a given cross-section, thus 
allowing simultaneous visualization of structure and blood 
flow (5). In addition to providing enhanced anatomic detail, 
OCTA allows quantitative metrics of the CNV area and 
generates data on vascular flow (2). Several studies have 
demonstrated that OCTA can accurately identify type 1 
and type 2 neovascularization (5-10), offering an unrivaled 
morphological characterization of the CNV net (e.g., tree-
like, glomerular, fragmented) that far exceeds FA, ICGA 
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and OCT. In addition, the presence of a fibrovascular 
capsule, afferent feeder trunk and peripheral anastomosis 
within the CNV can be clearly assessed (10). Preliminary 
findings from a recent study by de Carlo et al. (5) where 30 
eyes with OCTA and same-day FA were evaluated, reported 
a sensitivity of 50% (4/8) and a specificity of 91% (20/22) 
for CNV detection with OCTA. In the future, we may 
be able to correlate the morphological patterns of CNV 
with disease course, prognosis, and response to treatment. 
Furthermore, the non-invasive nature of the technique 
allows comprehensive lesion monitoring after treatment 
with anti-VEGF compounds. Quantitative measurements 
of the CNV flow area and flow index reported by Huang 
et al. (11) showed a rapid shutdown of flow over the initial 
2 weeks after treatment with anti-VEGF, followed by 
reappearance of the CNV channel by the fourth week 
and fluid reaccumulation at 6 weeks. As demonstrated by 
Lumbroso et al. (12) and Marques et al. (10), sequential 
examinations can shadow morphological changes in 
the neovascular network, closely tracking the timings 
of vascular network remodeling in patients undergoing 
treatment. Ultimately, this may allow the advent of tailored 
and customized treatment regimens for wet AMD patients, 
built upon the CNV net morphology at baseline and its 
response to treatment.
OCTA may also be useful in the screening of eyes at risk 
for CNV. Unilateral CNV is an established risk factor for 
the development of neovascularization in the fellow eye. 
Screening this population for early detection of CNV may 
have both therapeutic and prognostic implications. A pilot 
study by Palejwala et al. (13), showed that OCTA was able 
to identify focus of CNV that were not identifiable on FA 
and structural OCT. OCTA detects CNV by the presence 
of an abnormal pattern of vascular flow above the Bruch 
membrane, therefore being able to identify neovascular 
lesions that do not leak on FA. Whether nonexudative CNV 
is a predecessor of wet AMD or a distinct clinical entity is 
yet to be determined, as well as if we should or should not 
start anti-VEGF treatment in these cases.
In conclusion, this revolutionary imaging modality is 
redefining our understanding of wet AMD by conveying 
detailed, depth-resolved information on the retinal and 
choroidal vascular networks, both at a structural and 
functional level. The ability to accurately image CNV 
noninvasively and to qualitatively and quantitatively appraise 
its changes longitudinally, turn OCTA into an attractive 
alternative to more invasive imaging modalities such as FA 
and ICGA. However, attention should be drawn to first 
validate its accuracy and assess the reproducibility of its data 
in high-powered studies. Also, further study is needed to 
determine the clinical significance of nonexudative CNV, 
including how often these lesions convert to wet CNV and 
at what point, if any, anti-VEGF treatment is warranted. 
We embark on this new era of retinal imaging with great 
expectations in mind, hoping that OCTA can point out new 
clinical coordinates to improve the everyday management 
of exudative AMD. As new functionalities and technical 
enhancements continue to ripen, only further improvement 
is to be expected.
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